𝗠𝗔𝗦𝗛: 𝗿𝗮𝗻𝗸𝗶𝗻𝗴 𝘁𝗲𝗿𝗮𝗽𝗲́𝘂𝘁𝗶𝗰𝗼 (𝗲𝗳𝗶𝗰𝗮𝗰𝗶𝗮). @MarlonVFZR.

𝗠𝗔𝗦𝗛: 𝗿𝗮𝗻𝗸𝗶𝗻𝗴 𝘁𝗲𝗿𝗮𝗽𝗲́𝘂𝘁𝗶𝗰𝗼 (𝗲𝗳𝗶𝗰𝗮𝗰𝗶𝗮) 𝙍𝙚𝙨𝙤𝙡𝙪𝙘𝙞𝙤́𝙣 𝙙𝙚 𝙈𝘼𝙎𝙃 (𝙎𝙐𝘾𝙍𝘼) 1. 𝙋𝙚𝙜𝙤𝙯𝙖𝙛𝙚𝙧𝙢𝙞𝙣 (𝙁𝙂𝙁𝟮𝟭) → 91.7 2. 𝙎𝙪𝙧𝙫𝙤𝙙𝙪𝙩𝙞𝙙𝙚 (𝙂𝙇𝙋-𝟭/𝙂𝘾𝙂𝙍) → 90.8 3. 𝙏𝙞𝙧𝙯𝙚𝙥𝙖𝙩𝙞𝙙𝙚 (𝙂𝙄𝙋/𝙂𝙇𝙋-𝟭) → 84.7 4. 𝙍𝙚𝙨𝙢𝙚𝙩𝙞𝙧𝙤𝙢 (𝙏𝙃𝙍-β) → 61 5. 𝙎𝙚𝙢𝙖𝙜𝙡𝙪𝙩𝙞𝙙𝙚 (𝙂𝙇𝙋-𝟭) → 46 𝙈𝙖́𝙨 𝙖𝙡𝙡𝙖́ 𝙙𝙚 𝙧𝙚𝙨𝙤𝙡𝙪𝙘𝙞𝙤́𝙣 𝙁𝙞𝙗𝙧𝙤𝙨𝙞𝙨 → FGF21 (pegozafermin) líder 𝘾𝙑 𝙗𝙚𝙣𝙚𝙛𝙞𝙘𝙞𝙤 → tirzepatide ↓ MACE ↓ 𝙜𝙧𝙖𝙨𝙖 𝙝𝙚𝙥𝙖́𝙩𝙞𝙘𝙖 → resmetirom (MRI-PDFF) 𝘾𝙡𝙖𝙫𝙚 • Diferentes targets → 𝙩𝙚𝙧𝙖𝙥𝙞𝙖 𝙘𝙤𝙢𝙗𝙞𝙣𝙖𝙙𝙖 = 𝙛𝙪𝙩𝙪𝙧o.